BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28266251)

  • 1. An integrated analysis of cancer genes in clear cell renal cell carcinoma.
    Li J; Guo L; Ai Z
    Future Oncol; 2017 Apr; 13(8):715-725. PubMed ID: 28266251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
    Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
    Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis.
    Yang H; Li W; Lv Y; Fan Q; Mao X; Long T; Xie L; Dong C; Yang R; Zhang H
    Gene; 2019 Dec; 720():144103. PubMed ID: 31491435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
    Zhou L; Liu S; Li X; Yin M; Li S; Long H
    Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma.
    Evelönn EA; Landfors M; Haider Z; Köhn L; Ljungberg B; Roos G; Degerman S
    BMC Cancer; 2019 Jan; 19(1):65. PubMed ID: 30642274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated molecular analysis of clear-cell renal cell carcinoma.
    Sato Y; Yoshizato T; Shiraishi Y; Maekawa S; Okuno Y; Kamura T; Shimamura T; Sato-Otsubo A; Nagae G; Suzuki H; Nagata Y; Yoshida K; Kon A; Suzuki Y; Chiba K; Tanaka H; Niida A; Fujimoto A; Tsunoda T; Morikawa T; Maeda D; Kume H; Sugano S; Fukayama M; Aburatani H; Sanada M; Miyano S; Homma Y; Ogawa S
    Nat Genet; 2013 Aug; 45(8):860-7. PubMed ID: 23797736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated analysis of cancer genes in thyroid cancer.
    Chai L; Li J; Lv Z
    Oncol Rep; 2016 Feb; 35(2):962-70. PubMed ID: 26718127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.
    Wang J; Zhang Q; Zhu Q; Liu C; Nan X; Wang F; Fang L; Liu J; Xie C; Fu S; Song B
    J Cell Physiol; 2020 Feb; 235(2):1296-1308. PubMed ID: 31273792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
    Xu Q; Song A; Xie Q
    Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
    Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
    Wang Y; Wang Y; Liu F
    Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of DNA Methylation-Driven Genes in Clear Cell Renal Cell Carcinoma: A Study Based on Methylation and Transcriptome Analyses.
    Hu M; Xie J; Hou H; Liu M; Wang J
    Dis Markers; 2020; 2020():8817652. PubMed ID: 32733620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of cancer genes in hepatocellular carcinoma genomes.
    Zhang Z; Xu L; Sun C
    Oncol Lett; 2018 Feb; 15(2):1503-1510. PubMed ID: 29434842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.
    Ricketts CJ; Hill VK; Linehan WM
    PLoS One; 2014; 9(1):e85621. PubMed ID: 24454902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of
    Yang CA; Huang HY; Yen JC; Chang JG
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
    Kim D; Li R; Dudek SM; Wallace JR; Ritchie MD
    Pac Symp Biocomput; 2015; ():96-107. PubMed ID: 25592572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
    Hu F; Zeng W; Liu X
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
    Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
    Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.